{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:30:56Z","timestamp":1792225856925,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alpha-mannosidosis is a rare autosomal recessive lysosomal storage disorder (LSD) caused by reduced activity of alpha-mannosidase. Clinical manifestations include skeletal dysmorphism, mental impairment, hearing loss and recurrent infections. The severe type of the disease leads to early childhood death, while patients with milder forms can live into adulthood. There are no mortality studies to date. This study aimed to investigate the age at death and the causes of death of patients with alpha-mannosidosis who had not received disease-modifying treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinicians and LSD patient organisations (POs) from 33 countries were invited to complete a questionnaire between April\u2013May 2021. Cause of death and age at death was available for 15 patients. A literature review identified seven deceased patients that met the inclusion criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median age at death for patients reported by clinicians\/POs was 45\u00a0years (mean 40.3\u2009\u00b1\u200913.2, range 18\u201356, n\u2009=\u200915); 53% were female. One death occurred during the patient\u2019s second decade of life, and 14 out of 15 deaths (93.3%) during or after the patients\u2019 third decade, including four (26.7%) during their sixth decade. Median age at death for patients identified from the literature was 4.3\u00a0years (mean 15.7\u2009\u00b1\u200917.0, range 2.2\u201341, n\u2009=\u20097); two were female. Four of the seven patients (57.1%) died within the first decade of life.<\/jats:p>\n                <jats:p>Seven of 15 deaths (46.7%) reported by clinicians\/POs were recorded as pneumonia and three (20.0%) as cancer. Other causes of death included acute renal failure due to sepsis after intestinal perforation, decrease of red blood cells of unknown origin, kidney failure with systemic lupus erythematosus, aortic valve insufficiency leading to heart failure, and dehydration due to catatonia. Three out of seven causes of death (42.9%) reported in the literature were associated with septicaemia, two (28.6%) with respiratory failure and one to pneumonia following aspiration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study suggests that pneumonia has been the primary cause of death during recent decades in untreated patients with alpha-mannosidosis, followed by cancer. Determining the causes of mortality and life expectancy in these patients is crucial to further improve our understanding of the natural history of alpha-mannosidosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02422-6","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T11:02:43Z","timestamp":1658574163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mortality in patients with alpha-mannosidosis: a review of patients\u2019 data and the literature"],"prefix":"10.1186","volume":"17","author":[{"given":"Julia B.","family":"Hennermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-9174","authenticated-orcid":false,"given":"Eva M.","family":"Raebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Line","family":"Jacquemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Cefalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ballabeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"2422_CR1","unstructured":"Malm D, Nilssen \u00d8. Alpha-Mannosidosis. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews(\u00ae) [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132020; 2001 [updated 2019]."},{"key":"2422_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1172-8-88","volume":"8","author":"M Beck","year":"2013","unstructured":"Beck M, Olsen KJ, Wraith JE, Zeman J, Michalski JC, Saftig P, et al. Natural history of alpha mannosidosis a longitudinal study. Orphanet J Rare Dis. 2013;8:88.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"2422_CR3","first-page":"185","volume":"12","author":"L Borgwardt","year":"2014","unstructured":"Borgwardt L, Lund AM, Dali CI. Alpha-mannosidosis - a review of genetic, clinical findings and options of treatment. Pediatr Endocrinol Rev. 2014;12(Suppl 1):185\u201391.","journal-title":"Pediatr Endocrinol Rev"},{"key":"2422_CR4","unstructured":"Malm D, Nilssen \u00d8. Alpha-mannosidosis. Orphanet encyclopedia. 2016. Available online: https:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?lng=en&Expert=61. Accessed 1 October 2021."},{"issue":"1","key":"2422_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1\u20139.","journal-title":"Hum Genet"},{"key":"2422_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-3-21","volume":"3","author":"D Malm","year":"2008","unstructured":"Malm D, Nilssen \u00d8. Alpha-mannosidosis. Orphanet J Rare Dis. 2008;3:21.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"2422_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s004310000545","volume":"159","author":"D Malm","year":"2000","unstructured":"Malm D, Halvorsen DS, Tranebjaerg L, Sjursen H. Immunodeficiency in alpha-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes. Eur J Pediatr. 2000;159(9):699\u2013703.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"2422_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s10545-015-9862-4","volume":"38","author":"L Borgwardt","year":"2015","unstructured":"Borgwardt L, Thuesen AM, Olsen KJ, Fogh J, Dali CI, Lund AM. Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis. J Inherit Metab Dis. 2015;38(6):1119\u201327.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2422_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10545-013-9622-2","volume":"37","author":"D Malm","year":"2014","unstructured":"Malm D, Riise Stensland HM, Edvardsen \u00d8, Nilssen \u00d8. The natural course and complications of alpha-mannosidosis\u2013a retrospective and descriptive study. J Inherit Metab Dis. 2014;37(1):79\u201382.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2422_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/bmt.2011.99","volume":"47","author":"M Mynarek","year":"2012","unstructured":"Mynarek M, Tolar J, Albert MH, Escolar ML, Boelens JJ, Cowan MJ, et al. Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients. Bone Marrow Transplant. 2012;47(3):352\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"2422_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-015-0286-x","volume":"10","author":"L Borgwardt","year":"2015","unstructured":"Borgwardt L, Stensland HM, Olsen KJ, Wibrand F, Klenow HB, Beck M, et al. Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation. Orphanet J Rare Dis. 2015;10:70.","journal-title":"Orphanet J Rare Dis"},{"key":"2422_CR12","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.ymgmr.2019.100480","volume":"20","author":"J Adam","year":"2019","unstructured":"Adam J, Malone R, Lloyd S, Lee J, Hendriksz CJ, Ramaswami U. Disease progression of alpha-mannosidosis and impact on patients and carers\u2014A UK natural history survey. Mol Genet Metab Rep. 2019;20:100480.","journal-title":"Mol Genet Metab Rep"},{"issue":"4","key":"2422_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ymgme.2019.01.024","volume":"126","author":"N Guffon","year":"2019","unstructured":"Guffon N, Tylki-Szymanska A, Borgwardt L, Lund AM, Gil-Campos M, Parini R, et al. Recognition of alpha-mannosidosis in paediatric and adult patients: Presentation of a diagnostic algorithm from an international working group. Mol Genet Metab. 2019;126(4):470\u20134.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2422_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10545-018-0185-0","volume":"41","author":"L Borgwardt","year":"2018","unstructured":"Borgwardt L, Guffon N, Amraoui Y, Dali CI, De Meirleir L, Gil-Campos M, et al. Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial. J Inherit Metab Dis. 2018;41(6):1215\u201323.","journal-title":"J Inherit Metab Dis"},{"key":"2422_CR15","unstructured":"European Medicines Agency. Lamzede velmanase alfa. 2018. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lamzede. Accessed 20 October 2021."},{"issue":"4","key":"2422_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cge.12642","volume":"89","author":"L Borgwardt","year":"2016","unstructured":"Borgwardt L, Danielsen ER, Thomsen C, M\u00e5nsson JE, Taouatas N, Thuesen AM, et al. Alpha-mannosidosis: characterization of CNS pathology and correlation between CNS pathology and cognitive function. Clin Genet. 2016;89(4):489\u201394.","journal-title":"Clin Genet"},{"issue":"5","key":"2422_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jimd.12138","volume":"42","author":"M Zielonka","year":"2019","unstructured":"Zielonka M, Garbade SF, K\u00f6lker S, Hoffmann GF, Ries M. Ultra-orphan lysosomal storage diseases: A cross-sectional quantitative analysis of the natural history of alpha-mannosidosis. J Inherit Metab Dis. 2019;42(5):975\u201383.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2422_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13023-020-01549-8","volume":"15","author":"JB Hennermann","year":"2020","unstructured":"Hennermann JB, Guffon N, Cattaneo F, Ceravolo F, Borgwardt L, Lund AM, et al. The SPARKLE registry: protocol for an international prospective cohort study in patients with alpha-mannosidosis. Orphanet J Rare Dis. 2020;15(1):271.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2422_CR19","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.ymgme.2018.12.172","volume":"126","author":"JB Hennermann","year":"2019","unstructured":"Hennermann JB, Guffon N, Cattaneo F, Pirondi S, Borgwardt L, Lund AM, et al. The SPARKLE study: shedding light on alpha mannosidosis. Mol Genet Metab. 2019;126(2):S71\u20132.","journal-title":"Mol Genet Metab"},{"key":"2422_CR20","unstructured":"Government UK. F66 Guidance for doctors completing Medical Certificates of Cause of Death in England and Wales. In: Statistics HPOaOfN, editor.: Publishing Service Government UK; 2018."},{"key":"2422_CR21","unstructured":"UK Public General Acts. Births and Deaths Registration Act 1953; Part III; Searches and Certificates; Section 30. 1953 [updated 2016]. Available online: https:\/\/www.legislation.gov.uk\/ukpga\/Eliz2\/1-2\/20\/section\/30. Accessed 10 October 2021."},{"key":"2422_CR22","unstructured":"British Healthcare Business Intelligence Association. Legal and Ethical Guidelines for Healthcare Market Research. 2020."},{"issue":"1","key":"2422_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"issue":"2","key":"2422_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1442-200X.1995.tb03305.x","volume":"37","author":"S Camur","year":"1995","unstructured":"Camur S, Co\u015fkun T, Kiper N. Alpha-mannosidosis: the first Turkish case. Acta Paediatr Jpn. 1995;37(2):230\u20132.","journal-title":"Acta Paediatr Jpn"},{"issue":"12","key":"2422_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1203\/00006450-197612000-00008","volume":"10","author":"RJ Desnick","year":"1976","unstructured":"Desnick RJ, Sharp HL, Grabowski GA, Brunning RD, Quie PG, Sung JH, et al. Mannosidosis: clinical, morphologic, immunologic, and biochemical studies. Pediatr Res. 1976;10(12):985\u201396.","journal-title":"Pediatr Res"},{"issue":"5","key":"2422_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00005072-197709000-00004","volume":"36","author":"JH Sung","year":"1977","unstructured":"Sung JH, Hayano M, Desnick RJ. Mannosidosis: pathology of the nervous system. J Neuropathol Exp Neurol. 1977;36(5):807\u201320.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2422_CR27","first-page":"35","volume":"177","author":"PA Ockerman","year":"1967","unstructured":"Ockerman PA. Deficiency of beta-galactosidase and alpha-mannosidase\u2013primary enzyme defects in gargoylism and a new generalized disease? acta paediatr scand. Suppl. 1967;177:35\u20136.","journal-title":"Suppl"},{"issue":"3","key":"2422_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0022-3476(69)80259-3","volume":"75","author":"PA Ockerman","year":"1969","unstructured":"Ockerman PA. Mannosidosis: isolation of oligosaccharide storage material from brain. J Pediatr. 1969;75(3):360\u20135.","journal-title":"J Pediatr"},{"issue":"3","key":"2422_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0022-3476(69)80260-X","volume":"75","author":"B Kjellman","year":"1969","unstructured":"Kjellman B, Gamstorp I, Brun A, Ockerman PA, Palmgren B. Mannosidosis: a clinical and histopathologic study. J Pediatr. 1969;75(3):366\u201373.","journal-title":"J Pediatr"},{"issue":"10","key":"2422_CR30","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/adc.62.10.1044","volume":"62","author":"A Will","year":"1987","unstructured":"Will A, Cooper A, Hatton C, Sardharwalla IB, Evans DI, Stevens RF. Bone marrow transplantation in the treatment of alpha-mannosidosis. Arch Dis Child. 1987;62(10):1044\u20139.","journal-title":"Arch Dis Child"},{"issue":"1","key":"2422_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/0883073812470973","volume":"29","author":"R Govender","year":"2014","unstructured":"Govender R, Mubaiwa L. Alpha-mannosidosis: a report of 2 siblings and review of the literature. J Child Neurol. 2014;29(1):131\u20134.","journal-title":"J Child Neurol"},{"issue":"3","key":"2422_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1399-0004.1981.tb01829.x","volume":"20","author":"ML Mitchell","year":"1981","unstructured":"Mitchell ML, Erickson RP, Schmid D, Hieber V, Poznanski AK, Hicks SP. Mannosidosis: two brothers with different degrees of disease severity. Clin Genet. 1981;20(3):191\u2013202.","journal-title":"Clin Genet"},{"issue":"5","key":"2422_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1399-0004.1982.tb01447.x","volume":"22","author":"MA Patton","year":"1982","unstructured":"Patton MA, Barnes IC, Young ID, Harper PS, Pennock CA. Mannosidosis in two brothers: prolonged survival in the severe phenotype. Clin Genet. 1982;22(5):284\u20139.","journal-title":"Clin Genet"},{"issue":"5","key":"2422_CR34","first-page":"364","volume":"147","author":"C Tranchant","year":"1991","unstructured":"Tranchant C, Reis J, Dietemann JL, Lannes B, Maire I, Warter JM. Mannosidosis type II. Rev Neurol (Paris). 1991;147(5):364\u20137.","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"2422_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1086\/302183","volume":"64","author":"T Berg","year":"1999","unstructured":"Berg T, Riise HM, Hansen GM, Malm D, Tranebjaerg L, Tollersrud OK, et al. Spectrum of mutations in alpha-mannosidosis. Am J Hum Genet. 1999;64(1):77\u201388.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2422_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","volume":"32","author":"SA Jones","year":"2009","unstructured":"Jones SA, Alm\u00e1ssy Z, Beck M, Burt K, Clarke JT, Giugliani R, et al. Mortality and cause of death in mucopolysaccharidosis type ii-a historical review based on data from the hunter outcome survey (HOS). J Inherit Metab Dis. 2009;32(4):534\u201343.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2422_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13023-017-0717-y","volume":"12","author":"C Lavery","year":"2017","unstructured":"Lavery C, Hendriksz CJ, Jones SA. Mortality in patients with sanfilippo syndrome. Orphanet J Rare Dis. 2017;12(1):168.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2422_CR38","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41436-021-01244-4","volume":"23","author":"EJ Dogterom","year":"2021","unstructured":"Dogterom EJ, Wagenmakers MAEM, Wilke M, Demirdas S, Muschol NM, Pohl S, et al. Mucolipidosis type II and type III: a systematic review of 843 published cases. Genet Med. 2021;23(11):2047\u201356.","journal-title":"Genet Med"},{"issue":"160","key":"2422_CR39","doi-asserted-by":"publisher","first-page":"200363","DOI":"10.1183\/16000617.0363-2020","volume":"30","author":"R Borie","year":"2021","unstructured":"Borie R, Crestani B, Guyard A, Lidove O. Interstitial lung disease in lysosomal storage disorders. Eur Respir Rev. 2021;30(160):200363.","journal-title":"Eur Respir Rev"},{"issue":"8","key":"2422_CR40","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8(8):e1027\u201337.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"2422_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0029-1242458","volume":"22","author":"FA Haggar","year":"2009","unstructured":"Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22(4):191\u20137.","journal-title":"Clin Colon Rectal Surg"},{"issue":"1","key":"2422_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","volume":"36","author":"M de Fost","year":"2006","unstructured":"de Fost M, Vom Dahl S, Weverling GJ, Brill N, Brett S, H\u00e4ussinger D, et al. Increased incidence of cancer in adult gaucher disease in western Europe. Blood Cells Mol Dis. 2006;36(1):53\u20138.","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2422_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms20040843","volume":"20","author":"M W\u0105tek","year":"2019","unstructured":"W\u0105tek M, Piktel E, Wollny T, Durna\u015b B, Fiedoruk K, Lech-Mara\u0144da E, et al. Defective sphingolipids metabolism and tumor associated macrophages as the possible links between gaucher disease and blood cancer development. Int J Mol Sci. 2019;20(4):843.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2422_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/diseases5010008","volume":"5","author":"GM Pastores","year":"2017","unstructured":"Pastores GM, Hughes DA. Lysosomal storage disorders and malignancy. Diseases. 2017;5(1):8.","journal-title":"Diseases"},{"issue":"21","key":"2422_CR45","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.3390\/jcm10215029","volume":"10","author":"W Mauhin","year":"2021","unstructured":"Mauhin W, Levade T, Vanier MT, Froissart R, Lidove O. Prevalence of cancer in Acid sphingomyelinase deficiency. J Clin Med. 2021;10(21):5029.","journal-title":"J Clin Med"},{"issue":"10","key":"2422_CR46","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1002\/ajmg.a.62382","volume":"185","author":"JL Rodriguez-Gil","year":"2021","unstructured":"Rodriguez-Gil JL, Bianconi SE, Farhat N, Kleiner DE, Nelson M, Porter FD. Hepatocellular carcinoma as a complication of niemann-Pick disease type C1. Am J Med Genet A. 2021;185(10):3111\u20137.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2422_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-017-0701-6","volume":"12","author":"S Bird","year":"2017","unstructured":"Bird S, Hadjimichael E, Mehta A, Ramaswami U, Hughes D. Fabry disease and incidence of cancer. Orphanet J Rare Dis. 2017;12(1):150.","journal-title":"Orphanet J Rare Dis."},{"issue":"12","key":"2422_CR48","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1038\/s41436-019-0588-9","volume":"21","author":"J Shin","year":"2019","unstructured":"Shin J, Kim D, Kim H-L, Choi M, Koh Y, Yoon S-S. Oncogenic effects of germline variants in lysosomal storage disease genes. Genet Med. 2019;21(12):2695\u2013705.","journal-title":"Genet Med"},{"issue":"2","key":"2422_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ymgme.2020.04.001","volume":"130","author":"T Wiesinger","year":"2020","unstructured":"Wiesinger T, Schwarz M, Mechtler TP, Liebmann-Reindl S, Streubel B, Kasper DC. \u03b1-Mannosidosis\u2014an underdiagnosed lysosomal storage disease in individuals with an \u201cMPS-like\u201d phenotype. Mol Genet Metab. 2020;130(2):149\u201352.","journal-title":"Mol Genet Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02422-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02422-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02422-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T12:02:52Z","timestamp":1658577772000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02422-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2422"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02422-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required. Consent was obtained from participants. RDRP conduct their research in accordance with the British Healthcare Business Intelligence Association's Legal and Ethical Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JBH has received consulting fees and\/or travelling expenses by Amicus, Chiesi Farmaceutici S.p.A and Takeda; EMR is employed by the Rare Disease Research Partners, which supplies various professional services to Chiesi Farmaceutici S.p.A.; FD and AB are employees of Chiesi Farmaceutici S.p.A; GC has received advisory board fees from Chiesi Farmaceutici S.p.A.; M-LJ and DM have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}